DiaMedica Therapeutics
Earnings Surprise
Analysts estimated DMAC earnings of $-0.18 per share this quarter (Q4). DMAC's actual earnings were $-0.17 per share.
DMAC EPS surprise of 7.41%Analysts estimated DMAC earnings of $-0.19 per share this quarter (Q2). DMAC's actual earnings were $-0.18 per share.
DMAC EPS surprise of 7.12%Analysts estimated DMAC earnings of $-0.16 per share this quarter (Q3). DMAC's actual earnings were $-0.15 per share.
DMAC EPS surprise of 5.12%Analysts estimated DMAC earnings of $-0.16 per share this quarter (Q2). DMAC's actual earnings were $-0.13 per share.
DMAC EPS surprise of 18.65%Analysts estimated DMAC earnings of $-0.16 per share this quarter (Q1). DMAC's actual earnings were $-0.14 per share.
DMAC EPS surprise of 12.39%Analysts estimated DMAC earnings of $-0.14 per share this quarter (Q4). DMAC's actual earnings were $-0.14 per share.
DMAC EPS surprise of -1.96%Analysts estimated DMAC earnings of $-0.13 per share this quarter (Q3). DMAC's actual earnings were $-0.12 per share.
DMAC EPS surprise of -7.12%